ZIM Laboratories Limited (NSE:ZIMLAB)

ZIM Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	96	64.21	34.2	13.93	14.61
Short-Term Investments	-	2.84	-	-	-	-
Cash & Short-Term Investments	58.15	98.84	64.21	34.2	13.93	14.61
Cash Growth	-66.13%	53.95%	87.72%	145.62%	-4.69%	192.73%
Accounts Receivable	-	1,035	987.12	977.47	816.55	726.84
Other Receivables	-	0.34	0.28	0.39	1.45	1.38
Receivables	-	1,035	987.4	978.08	818.82	729.83
Inventory	-	812.63	537.06	752.84	543.47	563.89
Prepaid Expenses	-	18.3	17.55	9.81	14.04	14.65
Restricted Cash	-	-	-	-	-	3.31
Other Current Assets	-	311.49	303.27	346.43	527.35	494.01
Total Current Assets	-	2,276	1,909	2,121	1,918	1,820
Property, Plant & Equipment	-	1,804	1,216	1,069	1,052	1,122
Long-Term Investments	-	0.52	0.52	0.52	0.52	0.52
Goodwill	-	1.69	1.69	1.69	1.69	1.69
Other Intangible Assets	-	224.9	139.21	103.49	117.96	132.05
Long-Term Deferred Tax Assets	-	-	-	-	26.06	53.28
Other Long-Term Assets	-	160.13	149.3	120.57	131.61	123.47
Total Assets	-	4,468	3,416	3,416	3,248	3,253
Accounts Payable	-	623.81	582.39	810.71	648.71	660.01
Accrued Expenses	-	78.83	83.93	51.18	64.7	50.86
Short-Term Debt	-	550.4	228.8	173.45	446.31	496.9
Current Portion of Long-Term Debt	-	157.12	120.63	150.4	146.41	127.4
Current Portion of Leases	-	24.72	15.72	14.07	10.82	14.7
Current Income Taxes Payable	-	-	-	20.66	-	-
Current Unearned Revenue	-	4.88	3.66	4.48	5.3	5.43
Other Current Liabilities	-	154.5	72.74	234.17	98.12	79.04
Total Current Liabilities	-	1,594	1,108	1,459	1,420	1,434
Long-Term Debt	-	356.01	246.25	189.23	218.29	274.2
Long-Term Leases	-	29.5	10.18	7.22	1.68	6.26
Long-Term Deferred Tax Liabilities	-	101.01	48.03	3.63	-	-
Total Liabilities	-	2,081	1,412	1,659	1,640	1,715
Common Stock	-	487.26	487.26	162.42	162.42	161.81
Additional Paid-In Capital	-	80.3	80.3	409.89	409.89	406.31
Retained Earnings	-	1,585	1,416	1,177	1,031	961.28
Comprehensive Income & Other	-	234.97	19.61	8.23	4.59	8.82
Shareholders' Equity	2,428	2,387	2,003	1,757	1,608	1,538
Total Liabilities & Equity	-	4,468	3,416	3,416	3,248	3,253
Total Debt	1,007	1,118	621.58	534.37	823.51	919.47
Net Cash (Debt)	-948.76	-1,019	-557.38	-500.17	-809.58	-904.86
Net Cash Per Share	-19.43	-20.91	-11.44	-10.26	-16.63	-18.58
Filing Date Shares Outstanding	48.79	48.73	48.73	48.73	48.73	48.54
Total Common Shares Outstanding	48.79	48.73	48.73	48.73	48.73	48.54
Working Capital	-	682.23	801.61	662.27	497.25	385.96
Book Value Per Share	49.95	49.00	41.12	36.06	32.99	31.69
Tangible Book Value	2,145	2,161	1,863	1,652	1,488	1,404
Tangible Book Value Per Share	44.13	44.35	38.23	33.90	30.54	28.93
Land	-	96.16	96.16	96.16	96.16	102.33
Buildings	-	790.03	503.21	471.4	436.39	429.37
Machinery	-	1,338	1,018	943.73	872.98	833.54
Construction In Progress	-	235.16	178.39	50.97	45.61	47.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.